HOME >> BIOLOGY >> NEWS
Einstein researchers' prototype vaccine could provide improved protection against tuberculosis

(BRONX, NY) -- Using a novel approach, researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a prototype vaccine against tuberculosis (TB) that works better in animal models than the only TB vaccine now available. In this era of multi-drug resistant TB and growing numbers of people with active TB due to coinfection with HIV, the advance could herald a needed breakthrough against one of the worlds leading killers. Their study appears in the August issue of the Journal of Clinical Investigation.

TB is caused by Mycobacterium tuberculosis, a bacterial species that infects one third of the worlds population (up to 10% of whom will develop active TB) and causes up to three million deaths annually. The only available vaccine--known as Bacille Calmette-Gurin (BCG)is a live, attenuated (weakened) strain of M. bovis, which causes TB in cattle. Despite being the worlds most widely used vaccine, BCG fails to protect adults from TB infection and doesnt reliably stem the reactivation of pulmonary TB (the most common form of the disease) in adults.

Virtually all efforts to develop a better TB vaccine have focused on boosting BCGmodifying it to elicit a stronger immune response in people, says Dr. William Jacobs, Jr., co-senior author of the paper and a Howard Hughes Medical Institute investigator at Einstein as well as professor of microbiology & immunology and molecular genetics. But we feel that tweaking the marginally useful BCG vaccine is the wrong strategy. So weve started with virulent M. tuberculosisthe organism that actually causes TB in humansand are knocking out certain genes to yield a live, attenuated M. tuberculosis strain that still produces a strong immunological response that protects people.

TB bacteria invade human cells and then--successfully evading a persons immune response--lurk inside cells and multiply. A key evasion strategy involves preventing their host cells from undergoing apopto
'"/>

Contact: Larry Katzenstein
lkatzens@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
1-Aug-2007


Page: 1 2 3

Related biology news :

1. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
2. Einstein researchers discover radiation-eating fungi
3. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
4. Einstein researchers discover how a key dietary vitamin is absorbed
5. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
6. Team at CNSE and Einstein receive grant to develop worlds smallest cancer detection device
7. Einstein researchers demonstrate a novel approach to treating AIDS
8. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
9. Einstein researchers find key to unlocking worlds deadliest malaria parasite
10. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
11. Einstein researchers take the pulse of a gene in living cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research ... Stem Cell (hESC) Research - Global Strategic Business Report" report ... ... Cell (hESC) Research in US$ Million. Annual estimates and forecasts are ... are derived from primary and secondary research. The ...
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... , ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become ... hosted corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, ... the reason for its increasing popularity is due to its new team building format, a ...
Breaking Biology Technology:
Cached News: